IDH1 and central nervous system cancer: Likewise, the same IDH-wildtype glioma age and outcome associations observed in the other validation sets did not hold in the GLASS, likely due to patient inclusion bias, which is inherent in datasets made up of tumors known to have second resections (Additional file 2: Fig. 11) [16].